Investigations

The relationship between demoralization syndrome and death anxiety in stroke patients undergoing neuroendovascular procedures based on latent profile analysis

  • Xiang GAO ,
  • Beibei MA ,
  • Wanru BAO
Expand
  • Department of Interventional Radiography,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,Jiangsu,China

Received date: 2025-07-25

  Online published: 2025-11-26

Abstract

Objective To identify potential subtypes of demoralization syndrome among stroke patients undergoing neuroendovascular procedures using latent profile analysis, and to examine differences in death anxiety among these subtypes. Method This cross-sectional study used convenience sampling to recruit 202 stroke patients undergoing neuroendovascular procedures at a hospital from November 2024 to March 2025. Participants completed the General Information Questionnaire, Despair Scale (DS), and the Chinese version of the Templer's Death Anxiety Scale (CT-DAS). Using R software, we estimated a series of latent profile models (ranging from 2 to 6 profiles) based on four manifestations of demoralization syndrome: loss of meaning and purpose, dysphoria, helplessness and hopelessness, and sense of failure. Starting from the 2-profile model, we incrementally increased the number of profiles and compared model fit indices to identify the optimal solution. Subsequently, logistic regression analysis was conducted to identify the factors influencing DS scores according to the latent profile classifications. We compared DS scores across subgroups and performed bivariate correlation analysis between DS and CT-DAS subdimensions (Affective, Stress & Pain, Time Awareness, and Cognitive). Results The DS scores classified stroke patients into two distinct subtypes of demoralization syndrome: A Meaninglessness-Dysphoria Group (51.00%, 103/202) and a Helplessness-Hopelessness Group (49.00%, 99/202). The HHG demonstrated significantly higher proportions (P < 0.05) of female patients, those hospitalized for 6 ~ 10 days, recipients of arterial stenosis/occlusion surgery, individuals with junior high school or higher education, employed subjects, and rural residents compared to the MDG. Binary logistic regression analysis revealed: Lower probability of HHG membership for urban (OR= 0.159, P < 0.001) and city (OR = 0.224, P = 0.007) residents versus rural counterparts; Higher HHG probability in patients hospitalized 6-10 days versus 1 ~ 5 days (OR = 2.311, P = 0.017); Elevated HHG risk among junior high school (OR = 4.956, P < 0.001) and high school or above graduates (OR = 5.102, P = 0.001) relative to those with primary education or less; Increased HHG probability in aneurysm embolization (OR = 2.419, P = 0.040) and arterial stenosis/occlusion surgery (OR = 2.733, P = 0.014) recipients compared to cerebrovascular angiography patients. The HHG scored significantly lower on the cognitive dimension of death anxiety than the MDG (t = 2.421, P = 0.016), while showing no differences in affective, stress & pain, or time awareness dimensions (P > 0.05). Bivariate Pearson correlations indicated dysphoria (DS) positively correlated with Affective (r = 0.192, P = 0.006), Time Awareness (r = 0.172, P = 0.015), and Cognitive (r = 0.139, P = 0.049) of death anxiety. Conclusions Stroke patients undergoing neuroendovascular procedures exhibit elevated levels of death anxiety, with significant variations observed across different subtypes of demoralization syndrome. Residential location, hospitalization duration, anxiety severity, and surgical type constitute significant determinants of demoralization syndrome. Targeted clinical interventions should be implemented to alleviate demoralization severity and mitigate death anxiety.

Cite this article

Xiang GAO , Beibei MA , Wanru BAO . The relationship between demoralization syndrome and death anxiety in stroke patients undergoing neuroendovascular procedures based on latent profile analysis[J]. The Journal of Practical Medicine, 2025 , 41(22) : 3609 -3617 . DOI: 10.3969/j.issn.1006-5725.2025.22.020

References

[1] TATER P, PANDEY S. Post-stroke Movement Disorders: Clinical Spectrum, Pathogenesis, and Management[J]. Neurol India, 2021, 69(2): 272-283. doi:10.4103/0028-3886.314574
[2] FEIGIN V L, BRAININ M, NORRVING B, et al. World Stroke Organization: Global Stroke Fact Sheet 2025[J]. Int J Stroke, 2025, 20(2): 132-144. doi:10.1177/17474930241308142
[3] WITA K, KU?ACH A, WILKOSZ K, et al. Mechanical Thrombectomy in Acute Ischemic Stroke-The Role of Interventional Cardiologists: A Prospective Single-Center Study[J]. JACC Cardiovasc Interv, 2022, 15(5): 550-558. doi:10.1016/j.jcin.2021.11.041
[4] SHAO Q, LI Y, LIN L, et al. Demoralization syndrome and its impact factors among cancer patients in China[J]. J Psychosoc Oncol, 2024, 42(3):365-380. doi:10.1080/07347332.2023.2249895
[5] HSU C H, TUNG H H, WU Y C, et al. Demoralization syndrome among cardiac transplant recipients[J]. J Clin Nurs, 2022, 31(15/16): 2271-2286. doi:10.1111/jocn.16045
[6] WANG C, DENG Y, YAO Y, et al. Demoralization syndrome in burn patients: A cross-sectional study[J]. Burns, 2024, 50(6): 1640-1651. doi:10.1016/j.burns.2024.02.016
[7] 于冰, 陈梦霞, 王梦迪, 等. 脑卒中患者复发风险感知和健康行为的关系:自我效能和电子健康素养的链式中介作用[J]. 实用医学杂志, 2025, 41(4): 600-606.
[8] 池岩,张迪,高鹤枭,等. 数字技术辅助步行康复在脑卒中后偏瘫患者中的应用研究进展[J]. 实用医学杂志,2025, 41(15): 2426-2434.
[9] MATOS J, HENRIQUES A, MOURA A,et al. Professional reintegration of stroke survivors and their mental health, quality of life and community integration[J]. Qual Life Res, 2024,33(12):3259-3273. doi:10.1007/s11136-024-03797-8
[10] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国各类主要脑血管病诊断要点2019[J]. 中华神经科杂志, 2019, 52(9): 710-715.
[11] 王丹丹, 郑蔚, 康婷婷, 等. 简化版失志量表的汉化及信效度检验[J]. 现代预防医学, 2021, 48(4): 594-595.
[12] 杨红,韩丽沙,郭浩明. 死亡焦虑量表的跨文化调适[J]. 中国实用护理杂志, 2012, 28(31):53-57.
[13] TU W J, ZHAO Z, YIN P, et al. Estimated Burden of Stroke in China in 2020[J]. JAMA Netw Open, 2023, 6(3): e231455. doi:10.1001/jamanetworkopen.2023.1455
[14] CUI Y, HU Z, WANG L,et al. DL-3-n-Butylphthalide Ameliorates Post-stroke Emotional Disorders by Suppressing Neuroinflammation and PANoptosis[J]. Neurochem Res, 2024,49(8): 2215-2227. doi:10.1007/s11064-024-04171-3
[15] SOKOL L L, TROOST J P, BEGA D,et al. Death Anxiety in Huntington Disease: Longitudinal Heath-Related Quality-of-Life Outcomes[J]. J Palliat Med, 2023, 26(7): 907-914. doi:10.1089/jpm.2022.0160
[16] BOUTROS C F, KHAZAAL W, TALIANI M,et al. One-year recurrence of stroke and death in Lebanese survivors of first-ever stroke: Time-to-Event analysis[J]. Front Neurol, 2022,13(45):973-978. doi:10.3389/fneur.2022.973200
[17] 欧娜, 綦三阳, 胡小萍, 等. 癌症患者失志综合征现状及影响因素分析[J]. 护理学杂志, 2021, 36(22): 66-69.
[18] GBD 2019 Australia Collaborators. The burden and trend of diseases and their risk factors in Australia, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2023,8(8): e585-e599.
[19] CHUN H Y, FORD A, KUTLUBAEV M A,et al. Depression, Anxiety, and Suicide After Stroke: A Narrative Review of the Best Available Evidence[J]. Stroke, 2022,53(4):1402-1410. doi:10.1161/strokeaha.121.035499
[20] AN E, LO C, HALES S, et al. Demoralization and death anxiety in advanced cancer[J]. Psychooncology, 2018, 27(11): 2566-2572. doi:10.1002/pon.4843
Outlines

/